A detailed history of Bank Of America Corp transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 158,131 shares of AMPH stock, worth $6.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
158,131
Previous 155,267 1.84%
Holding current value
$6.19 Million
Previous $6.21 Million 23.57%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$36.99 - $50.09 $105,939 - $143,457
2,864 Added 1.84%
158,131 $7.67 Million
Q2 2024

Aug 14, 2024

BUY
$38.65 - $43.48 $1.16 Million - $1.3 Million
29,888 Added 23.84%
155,267 $6.21 Million
Q1 2024

May 15, 2024

SELL
$42.85 - $63.45 $3.86 Million - $5.72 Million
-90,153 Reduced 41.83%
125,379 $5.51 Million
Q4 2023

Feb 14, 2024

BUY
$44.49 - $62.93 $3.88 Million - $5.49 Million
87,218 Added 67.97%
215,532 $13.3 Million
Q2 2023

Aug 14, 2023

SELL
$35.77 - $58.38 $5.81 Million - $9.48 Million
-162,423 Reduced 55.87%
128,314 $7.37 Million
Q1 2023

May 12, 2023

BUY
$27.99 - $37.92 $6.32 Million - $8.56 Million
225,728 Added 347.23%
290,737 $10.9 Million
Q4 2022

Feb 10, 2023

SELL
$27.93 - $31.27 $663,560 - $742,912
-23,758 Reduced 26.76%
65,009 $1.82 Million
Q3 2022

Nov 14, 2022

BUY
$27.56 - $37.75 $133,941 - $183,465
4,860 Added 5.79%
88,767 $2.5 Million
Q2 2022

Aug 12, 2022

BUY
$29.79 - $42.29 $675,577 - $959,052
22,678 Added 37.04%
83,907 $2.92 Million
Q1 2022

May 16, 2022

BUY
$22.96 - $36.45 $112,595 - $178,750
4,904 Added 8.71%
61,229 $2.2 Million
Q4 2021

Feb 08, 2022

SELL
$18.14 - $23.29 $8,017 - $10,294
-442 Reduced 0.78%
56,325 $1.31 Million
Q3 2021

Nov 15, 2021

SELL
$17.83 - $21.49 $109,993 - $132,571
-6,169 Reduced 9.8%
56,767 $1.08 Million
Q2 2021

Sep 13, 2021

BUY
$17.11 - $20.92 $1.08 Million - $1.32 Million
62,936 New
62,936 $1.27 Million

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $1.92B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.